AI-based Social Software to Manage wARfarin Therapy

Clinical trial NCT03870581 · UNKNOWN

Trial details

NCT number: NCT03870581
Sponsor: Wuhan Asia Heart Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Anticoagulant-induced Bleeding Warfarin Sodium Causing Adverse Effects in Therapeutic Use

Start date: 2019-05-01
Primary completion: 2021-04-30
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.